3 months ago
20 ARTICLE AD
The Nigeria Centre for Disease Control and Prevention says 48 confirmed Mpox cases have been recorded out of 868 suspected cases across 35 local government areas in 19 states, and the Federal Capital Territory.
This was revealed in the Mpox situation report for week 34 (August 25) posted on the agency’s website on Friday.
The report, however, showed that no death has been recorded from the disease so far this year.
It said, “57 new suspected cases were reported in Epi week 34, 2024, compared with 25 cases reported in the previous week (Epi week 33).
“Eight confirmed cases were reported in week 34 compared with one confirmed case reported in week 33, 2024.
“Twenty States and the FCT have recorded at least one confirmed case across 35 Local Government Areas in 2024,” the report partly read.
The age distribution of the cumulative number of confirmed Mpox cases showed that 17 cases were recorded among ages 0-10, seven cases were recorded among ages 11-20, nine cases were recorded among 21-30, eight cases were recorded among ages 31-40, and seven cases were recorded among ages 41-50.
The cases were recorded in Lagos (one), Rivers (two), Bayelsa (six), Abia (one), Delta (two), Imo (one), Edo (one), FCT (two), Anambra (two), Cross River (five).
Others are Plateau (two), Akwa Ibom (four), Nasarawa (one), Oyo (one), Kaduna (one), Ebonyi (one), Benue (three), Enugu (eight), Osun (two), Kebbi (one), and Zamfara (one).
Mpox is a rare viral zoonotic infectious disease (i.e. an infection transmitted from animals to humans) that occurs sporadically, primarily in remote villages of Central and West Africa, near tropical rainforests. It is caused by the Mpox virus, which belongs to the Orthopoxvirus genus in the family Poxviridae.
The Orthopoxvirus genus also includes the variola virus (the cause of smallpox), the vaccinia virus (used in the smallpox eradication vaccine), and the cowpox virus (used in earlier smallpox vaccines). Following the eradication of smallpox, the Mpox virus has emerged as the most significant Orthopoxvirus.
On August 13, 2024, the Africa Centres for Disease Control and Prevention declared Mpox a public health emergency of continental security, acting under its mandate to address significant public health threats.
The NCDC noted that the National Mpox multi-sectoral and multi-partner Emergency Operation Centre continues to coordinate the response in the country.
Meanwhile, the National Primary Health Care Development Agency has set October 8, 2024 as a tentative date to commence vaccination for Mpox.
Head of the Public Relations Unit at the NPHCDA, Remi Adeleke, who disclosed this exclusively to Our Correspondent, also stated that vaccine deployment would begin from October 3 to 6, 2024.
Adeleke said, “The date for vaccine deployment based on the current chronogram is from October 3rd to 6th, 2024. Time to align with the three to six weeks period from vaccine receipt on the 27th of August for NAFDAC to conclude the regulatory procedures of sampling, traceability and lab analysis.
“The tentative implementation date is 8th October 8, 2024.
“Due to limited available doses (9,980) of the Jynneos MPox vaccine, the quantities will be split evenly (1,996 doses) across the five states for implementation.
“Specific states for implementation are being evaluated based on the current trend of cases in collaboration with the Nigeria Centre for Disease Control and Prevention.”
